Jean-Philippe GUILLOUX, Ph.D.
Affiliations: | Pharmacology | Université Paris Sud, Bures-sur-Yvette, Île-de-France, France |
Area:
NeuropharmacologyWebsite:
http://www.neuropharmacologie.u-psud.frGoogle:
"Jean-Philippe GUILLOUX"Mean distance: 15.6 (cluster 6) | S | N | B | C | P |
Parents
Sign in to add mentorEtienne Sibille | post-doc | 2008-2011 | University of Toronto (CAMH) |
Alain Gardier | research scientist | Université Paris Sud |
Children
Sign in to add traineeFlavie Darcet | grad student | Université Paris Sud | |
Maryam Mekiri | grad student | Université Paris Sud | |
Lin Xia | grad student | Université Paris Sud |
Collaborators
Sign in to add collaboratorDenis David | collaborator | Université Paris Sud | |
Bruno Guiard | collaborator | Université Paris Sud |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Loan Nguyen TM, Guilloux JP, Defaix C, et al. (2024) Ketamine metabolism via hepatic CYP450 isoforms contributes to its sustained antidepressant actions. Neuropharmacology. 110065 |
Guilloux JP, Nguyen TML, Gardier AM. (2023) [Ketamine: a neuropsychotropic drug with an innovative mechanism of action]. Biologie Aujourd'Hui. 217: 133-144 |
Martin H, Coursan A, Lallement J, et al. (2023) Serotonergic neurons are involved in the counter-regulatory response to hypoglycemia. Journal of Neuroendocrinology. e13344 |
Doan J, Defaix C, Mendez-David I, et al. (2023) Intrahippocampal injection of a selective blocker of NMDA receptors containing the GluN2B subunit, Ro25-6981, increases glutamate neurotransmission and induces antidepressant-like effects. Fundamental & Clinical Pharmacology |
Lebeau RH, Mendez-David I, Kucynski-Noyau L, et al. (2022) Peripheral proteomic changes after electroconvulsive seizures in a rodent model of non-response to chronic fluoxetine. Frontiers in Pharmacology. 13: 993449 |
Gardier A, Nguyen TML, Defaix C, et al. (2020) Efficacy of Intranasal Delivery of (R,S)-Ketamine to the Mouse Brain Biological Psychiatry. 87: S390-S391 |
Mendez-David I, Guilloux J, Shah A, et al. (2020) Serotonin 3 Receptor Blockade is Involved in Vortioxetine -Induced Prevention of Anxiety/Depression Relapse Phenotype Biological Psychiatry. 87 |
Prevot T, Li G, Knutson D, et al. (2020) Improved Cognitive Functions and Neurotrophic Effects of a Novel Molecule Enhancing α5-GABA-A Receptor Function in Adult or Aged Mice Biological Psychiatry. 87: S404 |
Mendez-David I, Guilloux J, Tritschler L, et al. (2019) S137. Long-Term Effects of Vortioxetine (Lu AA21004) on Adult Hippocampal Neurogenesis Prevents Reinstatement of Anxiety/Depression-Like Phenotype in Mice Biological Psychiatry. 85 |
Loan Nguyen TM, Defaix C, Mendez-David I, et al. (2019) S136. Is Ketamine Metabolism to Norketamine and (2R,6R)-HNK Necessary for its Sustained Antidepressant-Like Activity and Cortical Neurotransmitter Release in Mice? Biological Psychiatry. 85: S349 |